[Thrombolysis in pulmonary embolism with high mortality risk: Experience of a cardiology department in sub-Saharan Africa]

Ann Cardiol Angeiol (Paris). 2019 Feb;68(1):28-31. doi: 10.1016/j.ancard.2018.08.026. Epub 2018 Oct 2.
[Article in French]

Abstract

Introduction: High-risk pulmonary embolism (PE) accounts for 5% of total acute PE and is a life-threatening emergency requiring immediate therapeutic management by fibrinolysis. The objective of this work is to describe the experience of thrombolysis in high-risk PE in a cardiology department in Togo.

Patients and methods: This is an analytical and descriptive study carried out in the cardiology department of the Campus teaching hospital of Lomé over a period of 5 years (August 2012 to July 2017) concerning patients hospitalized for high-risk mortality PE and having undergone streptokinase thrombolysis.

Results: Twenty-eight of the 102 PE were at high risk of mortality (27.5%). They were 9 men and 19 women with an average age of 61.9±14.1 years. The mean systolic blood pressure was 65mmHg and 50% of the patients were placed on dobutamine. Thrombolysis was performed in 22 of the 28 patients (78.6%). Eighteen patients had a short protocol and 4 a long protocol. The mortality rate was 32.1% or 13.6% in the thrombolysis PE versus 100% in the non-thrombolysis PE (P=0.01). Causes of death in thrombolysis were persistent shock (2 cases) at the end of thrombolysis and sudden death occurred 1 month after hospitalization. The average hospital stay was 18.8 days.

Conclusion: The high-risk PE remains today a pathology burdened with heavy mortality. Thrombolysis remains the first treatment to reduce this mortality.

Keywords: Embolie pulmonaire; Haut risque; High risk; Mortality; Mortalité; Pulmonary embolism; Thrombolyse; Thrombolysis; Togo.

MeSH terms

  • Adult
  • Aged
  • Cardiology Service, Hospital
  • Cardiotonic Agents / therapeutic use
  • Dobutamine / therapeutic use
  • Drug Administration Schedule
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Hospitals, Teaching
  • Humans
  • Length of Stay / statistics & numerical data
  • Male
  • Middle Aged
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / mortality*
  • Streptokinase / administration & dosage
  • Thrombolytic Therapy / statistics & numerical data*
  • Togo / epidemiology

Substances

  • Cardiotonic Agents
  • Fibrinolytic Agents
  • Dobutamine
  • Streptokinase